The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Theory and practice of size exclusion chromatography for the analysis of protein aggregates
Open accessAbstract
Size exclusion chromatography (SEC) is a historical technique widely employed for the detailed characterization of therapeutic proteins and can be considered as a reference and powerful technique for the qualitative and quantitative evaluation of aggregates. The main advantage of this approach is the mild mobile phase conditions that permit the characterization of proteins with minimal impact on the conformational structure and local environment. Despite the fact that the chromatographic behavior and peak shape are hardly predictable in SEC, some generic rules can be applied for SEC method development, which are described in this review. During recent years, some improvements were introduced to conventional SEC that will also be discussed. Of these new SEC characteristics, we discuss (i) the commercialization of shorter and narrower columns packed with reduced particle sizes allowing an improvement in the resolution and throughput; (ii) the possibility of combining SEC with various detectors, including refractive index (RI), ultraviolet (UV), multi-angle laser light scattering (MALLS) and viscometer (IV), for extensive characterization of protein samples and (iii) the possibility of hyphenating SEC with mass spectrometry (MS) detectors using an adapted mobile phase containing a small proportion of organic modifiers and ion-pairing reagents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of Fluorescence Spectroscopy
Lakowicz, J. R. (1999) · Springer eBooks · doi:10.1007/978-1-4757-3061-6 · Cited by 26,947
Encyclopedia of Analytical Chemistry: Applications, Theory and Instrumentation
(2006) · Wiley eBooks · doi:10.1002/9780470027318 · Cited by 7,403
How to study proteins by circular dichroism
Kelly, S. M., Jess, T. J., & Price, N. C. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.06.005 · Cited by 3,351
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., & Stefani, M. (2002) · Nature · doi:10.1038/416507a · Cited by 2,434
Effects of protein aggregates: An immunologic perspective
Rosenberg, A. S. (2006) · The AAPS Journal · doi:10.1208/aapsj080359 · Cited by 1,355
Instability, stabilization, and formulation of liquid protein pharmaceuticals
Wang, W. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00152-0 · Cited by 1,064
Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis
Booth, D. R., Sunde, M., Bellotti, V., Robinson, C. V., Hutchinson, W. L., Fraser, P. E., Hawkins, P. N., Dobson, C. M., Radford, S. E., Blake, C. C. F., et al. (1997) · Nature · doi:10.1038/385787a0 · Cited by 1,048
Protein aggregation and its inhibition in biopharmaceutics
Wang, W. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.11.014 · Cited by 983
Protein aggregation: Pathways, induction factors and analysis
Mahler, H.-C., Friess, W., Grauschopf, U., & Kiese, S. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21566 · Cited by 901
Striegel, A. M., Yau, W. W., Kirkland, J. J., & Bly, D. D. (2009) · Wiley eBooks · doi:10.1002/9780470442876 · Cited by 855
Characterization of Therapeutic Antibodies and Related Products
Beck, A., Wagner-Rousset, E., Ayoub, D., Van Dorsselaer, A., & Sanglier-Cianférani, S. (2013) · Analytical Chemistry · doi:10.1021/ac3032355 · Cited by 587
Self-citationHong, P., Koza, S., & Bouvier, E. S. P. (2012) · Journal of Liquid Chromatography & Related Technologies · doi:10.1080/10826076.2012.743724 · Cited by 557
Cleland, J. L., Powell, M., & Shire, S. J. (1993) · PubMed · Cited by 543
Aggregates in monoclonal antibody manufacturing processes
Vázquez‐Rey, M., & Lang, D. A. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.23155 · Cited by 479
Section XXV Adsorption Chromatographs
(2009) · Biotechnology · doi:10.1201/9781420084498-32 · Cited by 452
Uversky, V. N. (1993) · Biochemistry · doi:10.1021/bi00211a042 · Cited by 437
Reduction−Alkylation Strategies for the Modification of Specific Monoclonal Antibody Disulfides
Sun, M. M. C., Beam, K. S., Cerveny, C. G., Hamblett, K. J., Blackmore, R. S., Torgov, M. Y., Handley, F. G. M., Ihle, N. C., Senter, P. D., & Alley, S. C. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050201y · Cited by 370
Principles, approaches, and challenges for predicting protein aggregation rates and shelf life
Weiss, W. F., Young, T. M., & Roberts, C. J. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21521 · Cited by 308
What's fueling the biotech engine—2012 to 2013
(Rob) Aggarwal, S. (2014) · Nature Biotechnology · doi:10.1038/nbt.2794 · Cited by 254
Biosimilar, Biobetter, and Next Generation Antibody Characterization by Mass Spectrometry
Beck, A., Sanglier-Cianférani, S., & Van Dorsselaer, A. (2012) · Analytical Chemistry · doi:10.1021/ac3002885 · Cited by 247
Self-citationRivalain, N., Roquain, J., & Demazeau, G. (2010) · Biotechnology Advances · doi:10.1016/j.biotechadv.2010.04.001 · Cited by 229
Arakawa, T., Ejima, D., Li, T., & Philo, J. S. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21974 · Cited by 224
Effects of high pressure in liquid chromatography
Martin, M., & Guiochon, G. (2005) · Journal of Chromatography A · doi:10.1016/j.chroma.2005.06.005 · Cited by 213
The use of asymmetrical flow field-flow fractionation in pharmaceutics and biopharmaceutics
Fraunhofer, W., & Winter, G. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.034 · Cited by 201
GARCIA, M. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2005.03.041 · Cited by 198
Aggregation of Therapeutic Proteins
(2010) · Wiley eBooks · doi:10.1002/9780470769829 · Cited by 195
Fluorescence Spectroscopy in Peptide and Protein Analysis
Ladokhin, A. S. (2000) · Encyclopedia of Analytical Chemistry · doi:10.1002/9780470027318.a1611 · Cited by 182
Protein Determination by UV Absorption
Aitken, A., & Learmonth, M. (1996) · Springer Protocols Handbooks · doi:10.1007/978-1-60327-259-9_1 · Cited by 180
Therapeutic Fc-fusion proteins and peptides as successful alternatives to antibodies
Beck, A., & Reichert, J. M. (2011) · mAbs · doi:10.4161/mabs.3.5.17334 · Cited by 179
Self-citationFekete, S., Veuthey, J.-L., & Guillarme, D. (2012) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2012.03.024 · Cited by 160
Self-citationLazar, A. C., Wang, L., Blättler, W. A., Amphlett, G. W., Lambert, J. M., & Zhang, W. (2005) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.1987 · Cited by 155
Arginine as an effective additive in gel permeation chromatography
Ejima, D., Yumioka, R., Arakawa, T., & Tsumoto, K. (2005) · Journal of Chromatography A · doi:10.1016/j.chroma.2005.07.086 · Cited by 152
Beck, A., & Reichert, J. M. (2013) · mAbs · doi:10.4161/mabs.25864 · Cited by 146
Self-citationNonideal size-exclusion chromatography of proteins: Effects of pH at low ionic strength
Kopaciewicz, W., & Regnier, F. E. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90102-6 · Cited by 142
Predicting solution aggregation rates for therapeutic proteins: Approaches and challenges
Roberts, C. J., Das, T. K., & Şahin, E. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.03.064 · Cited by 141
King, D., Dubowchik, G. M., Mastalerz, H. A., Willner, D., Hofstead, S. J., Firestone, R. A., Lasch, S. J., & Trail, P. A. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020149g · Cited by 135
Brummitt, R. K., Nesta, D. P., Chang, L., Chase, S. F., Laue, T. M., & Roberts, C. J. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22448 · Cited by 135
Antibody-drug conjugate model fast characterization by LC-MS following IdeS proteolytic digestion
Wagner‐Rousset, E., Janin-Bussat, M.-C., Colas, O., Excoffier, M., Ayoub, D., Haeuw, J., Rilatt, I., Perez, M., Corvaïa, N., & Beck, A. (2013) · mAbs · doi:10.4161/mabs.26773 · Cited by 135
Self-citationThe protein protocols handbook
Lewis, J. (1997) · Biochemical Education · doi:10.1016/s0307-4412(97)85226-0 · Cited by 134
Analytical characterization of biosimilar antibodies and Fc-fusion proteins
Beck, A., Diemer, H., Ayoub, D., Debaene, F., Wagner‐Rousset, E., Carapito, C., DORSSELAER, A. V., & Cianférani, S. (2013) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2013.02.014 · Cited by 134
Self-citationLullien‐Pellerin, V., & Balny, C. (2002) · Innovative Food Science & Emerging Technologies · doi:10.1016/s1466-8564(02)00045-0 · Cited by 133
Kaletaş, B. K., Filipe, V., van Duijn, E., Kasper, P. T., Vreeken, R. J., Heck, A. J. R., & Jiskoot, W. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0224-5 · Cited by 120
Some potentialities and drawbacks of contemporary size-exclusion chromatography
Štulı́k, K., Pacáková, V., & Tichá, M. (2003) · Journal of Biochemical and Biophysical Methods · doi:10.1016/s0165-022x(03)00053-8 · Cited by 111
High hydrostatic pressure as a tool to study protein aggregation and amyloidosis
Randolph, T. W., Seefeldt, M. B., & Carpenter, J. F. (2002) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(01)00346-6 · Cited by 109
Ye, H. (2006) · Analytical Biochemistry · doi:10.1016/j.ab.2006.05.025 · Cited by 103
Li, Y., Ogunnaike, B. A., & Roberts, C. J. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21869 · Cited by 103
Fast, reproducible size-exclusion chromatography of biological macromolecules
Ricker, R. D., & Sandoval, L. A. (1996) · Journal of Chromatography A · doi:10.1016/0021-9673(96)00283-x · Cited by 93
High Pressure Induces Scrapie-like Prion Protein Misfolding and Amyloid Fibril Formation
Torrent, J., Álvarez‐Martínez, M. T., Harricane, M.-C., Heitz, F., Liautard, J., Balny, C., & Lange, R. (2004) · Biochemistry · doi:10.1021/bi049939d · Cited by 93
Brummitt, R. K., Nesta, D. P., Chang, L., Kroetsch, A. M., & Roberts, C. J. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22447 · Cited by 93
Hawe, A., Frieß, W., Sutter, M., & Jiskoot, W. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2008.03.050 · Cited by 91
A critical reappraisal of Waddell's technique for ultraviolet spectrophotometric protein estimation
Wolf, P. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90062-3 · Cited by 89
Analytical approaches to assess the degradation of therapeutic proteins
Filipe, V., Hawe, A., Carpenter, J. F., & Jiskoot, W. (2013) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2013.05.005 · Cited by 82
Debaene, F., Wagner‐Rousset, E., Colas, O., Ayoub, D., Corvaïa, N., DORSSELAER, A. V., Beck, A., & Cianférani, S. (2013) · Analytical Chemistry · doi:10.1021/ac402237v · Cited by 81
Self-citationHollander, I. J., Kunz, A., & Hamann, P. R. (2007) · Bioconjugate Chemistry · doi:10.1021/bc700321z · Cited by 80
Liu, H., Gaza‐Bulseco, G., & Chumsae, C. M. (2009) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2009.08.015 · Cited by 79
Hartmann, W. K., Saptharishi, N., Yang, X. Y., Mitra, G., & Soman, G. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2003.10.031 · Cited by 78
Fekete, S., Veuthey, J., McCalley, D. V., & Guillarme, D. (2012) · Journal of Chromatography A · doi:10.1016/j.chroma.2012.10.056 · Cited by 77
Self-citationPharmaceutical biotechnology - concepts and applications
Mallela, K. M. G. (2010) · Human Genomics · doi:10.1186/1479-7364-4-3-218 · Cited by 76
In-Line Desalting Mass Spectrometry for the Study of Noncovalent Biological Complexes
Cavanagh, J., Benson, L. M., Thompson, R. J., & Naylor, S. (2003) · Analytical Chemistry · doi:10.1021/ac030182q · Cited by 73
Quiles, S., Raisch, K. P., Sanford, L. L., Bonner, J. A., & Safavy, A. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900899g · Cited by 70
Siz-exclusion high-performance liquid chromatography of peptides
Mant, C. T., Parker, J. M. R., & Hodges, R. S. (1987) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)84993-1 · Cited by 69
Enhanced Potency of Human Calcitonin When Fibrillation is Avoided
Cudd, A., Arvinte, T., Das, R. G., Chinni, C., & MacIntyre, I. M. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840610 · Cited by 63
Fekete, S., Ganzler, K., & Guillarme, D. (2013) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2013.02.013 · Cited by 61
Self-citationAnalysis of pH-dependent protein interactions with gel filtration medium
Golovchenko, N. P., Kataeva, I. A., & Akimenko, V. K. (1992) · Journal of Chromatography A · doi:10.1016/0021-9673(92)80229-n · Cited by 59
Fast Liquid Chromatography for High‐Throughput Screening of Polymers
Pasch, H., & Kilz, P. (2003) · Macromolecular Rapid Communications · doi:10.1002/marc.200390005 · Cited by 57
Diederich, P., Hansen, S. K., Oelmeier, S. A., Stolzenberger, B., & Hubbuch, J. J. (2011) · Journal of Chromatography A · doi:10.1016/j.chroma.2011.09.086 · Cited by 51
He, Y., Friese, O. V., Schlittler, M. R., Wang, Q., Xun, Y., Bass, L. A., & Jones, M. T. (2012) · Journal of Chromatography A · doi:10.1016/j.chroma.2012.09.012 · Cited by 48
Quantitation of non-ideal behavior in protein size-exclusion chromatography
Dubin, P. L., Edwards, S. L., Mehta, M. S., & Tomalia, D. A. (1993) · Journal of Chromatography A · doi:10.1016/0021-9673(93)83113-7 · Cited by 44
Mobile phase containing arginine provides more reliable SEC condition for aggregation analysis
Yumioka, R., Sato, H., Tomizawa, H., Yamasaki, Y., & Ejima, D. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21857 · Cited by 44
Protein quantitation using various modes of high performance liquid chromatography
Grotefend, S., Kaminski, L., Wroblewitz, S., Deeb, S. E., Kühn, N., Reichl, S., Limberger, M., Watt, S., & Wätzig, H. (2012) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2012.08.024 · Cited by 40
Aggregation and Immunogenicity of Therapeutic Proteins
Filipe, V., Hawe, A., Schellekens, H., & Jiskoot, W. (2010) · Wiley eBooks · doi:10.1002/9780470769829.ch10 · Cited by 39
Beaulieu, M., Corredig, M., Turgeon, S. L., Wicker, L., & Doublier, J. L. (2004) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2004.10.025 · Cited by 37
Woodard, J., Lau, H., & Latypov, R. F. (2013) · Analytical Chemistry · doi:10.1021/ac401455f · Cited by 36
Qian, J., Tang, Q., Cronin, B., et al. (2008) · Journal of Chromatography A · doi:10.1016/j.chroma.2008.01.040 · Cited by 35
Experimental Detection and Characterization of Protein Aggregates
Sharma, V. K., & Kalonia, D. S. (2010) · Wiley eBooks · doi:10.1002/9780470769829.ch5 · Cited by 32
Wong, C., Strachan-Mills, C., & Burman, S. (2012) · Journal of Chromatography A · doi:10.1016/j.chroma.2012.10.064 · Cited by 31
Interlaced size exclusion liquid chromatography of monoclonal antibodies
Farnan, D., Moreno, G. T., Stults, J. T., Becker, A., Tremintin, G., & van Gils, M. (2009) · Journal of Chromatography A · doi:10.1016/j.chroma.2009.10.045 · Cited by 26
Rea, J. C., Moreno, G. T., Vampola, L., Lou, Y., van Haan, B., Tremintin, G., Simmons, L. C., Nava, A., Wang, Y. J., & Farnan, D. (2011) · Journal of Chromatography A · doi:10.1016/j.chroma.2011.11.025 · Cited by 20
Pretorius, N. O., Rode, K., Simpson, J. M., et al. (2013) · Analytica Chimica Acta · doi:10.1016/j.aca.2013.07.030 · Cited by 15
Rea, J. C., Lou, Y., Cuzzi, J., Hu, Y., de Jong, I., Wang, Y. J., & Farnan, D. (2012) · Journal of Chromatography A · doi:10.1016/j.chroma.2012.10.051 · Cited by 12
Cited by
Li, X., Corbett, A. L., Taatizadeh, E., Tasnim, N., Little, J. P., Garnis, C., Daugaard, M., Guns, E., Hoorfar, M., & Li, I. T. S. (2019) · APL Bioengineering · doi:10.1063/1.5087122 · Cited by 564
Physicochemical Stability of Monoclonal Antibodies: A Review
Le Basle, Y., Chennell, P., Tokhadze, N., Astier, A., & Sautou, V. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.08.009 · Cited by 429
Food‐Grade Covalent Complexes and Their Application as Nutraceutical Delivery Systems: A Review
Liu, F., Ma, C., Gao, Y., & McClements, D. J. (2017) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12229 · Cited by 398
de Castro, R. J. S., & Sato, H. H. (2015) · Food Research International · doi:10.1016/j.foodres.2015.05.013 · Cited by 280
Ion-exchange chromatography for the characterization of biopharmaceuticals
Fekete, S., Beck, A., Veuthey, J.-L., & Guillarme, D. (2015) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2015.02.037 · Cited by 261
Self-citation
Metadata
- Authors
- Fekete, S., Beck, A., Veuthey, J.-L., & Guillarme, D.
- Venue
- Journal of Pharmaceutical and Biomedical Analysis
- Publisher
- Elsevier BV
- Published
- 2014-12
- Volume
- 101
- Pages
- 161-173
- ISSN
- 0731-7085 (ISSN-L)
- OpenAlex
- W2011291072
- Cited by
- 324
- References
- 81
- FWCI
- 10.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.